Ataxia Investigators Meetings

Launched in 2005, NAF’s biennial Ataxia Investigators Meeting (AIM) brings together world-leading Ataxia clinicians and scientists who are working to accelerate the pace of Ataxia research, better understand the disease, and develop therapies.


Due to the evolving and unpredictable international situation with the novel coronavirus COVID-19, the National Ataxia Foundation (NAF) Medical Research Advisory Board has chosen at this time to cancel all activities involving all NAF sponsored meetings in Denver from March 2nd-7th including ARCA Global, the Ataxia Investigators Meeting (AIM), and the Annual Ataxia Conference (AAC). Although we understand this may create an inconvenience to many of you, we cannot, at this time, assure attendees that the risk of possible infection is minimal as this meeting will bring international travelers from geographic areas with active infections (e.g., China, Iran, Italy, Japan, South Korea). Lastly, we cannot risk exposure of our vulnerable patient population to infection or, by proxy, risk bringing health care practitioners from around the country who serve vulnerable populations in close proximity to travelers from infected geographic areas. We also cannot, in good conscience, risk exposure to the city of Denver, which at present has no confirmed cases. Although the risk may be considered low by some, the situation is changing on a daily basis, both nationally and internationally, and we have therefore chosen to adopt a zero-risk policy to prevent any potential harm to those we care and serve. Thank you for your understanding. 


All of the details on reimbursement will be provided at a later date. 

Please email with questions or concerns.

AIM 2020: Leveraging Therapeutic Opportunity into Novel Treatment Paradigms

AIM 2020 will be held on March 3-6, 2020 at the Sheraton Denver Downtown.

AIM begins at 5:00 p.m. on Tuesday, March 3 with a Welcome Reception and opening remarks from Dr. Albert La Spada. View the full agenda. The scientific sessions begin on Wednesday, March 4 at 8:30 a.m. and end on Friday, March 6 at 11:30 a.m.

This meeting will address 5 themes:

  1. Basic Cerebellar function and dysfunction.
  2. Disease modeling and mechanisms.
  3. Neuroprotective targets and strategies.
  4. Biomarker discovery and Clinical disease phenotyping.
  5. Clinical trial organization.

The meeting chair is Dr. Al La Spada at Duke University and co-chair is Dr. Stefan Pulst at University of Utah. 

View the 2020 AIM Program.

Registration Information

Please register early, as space is limited. The AIM registration fees are:

Hotel Reservations

The Sheraton Denver Downtown is the official conference hotel of the 2020 NAF Ataxia Investigators Meeting. It is located at 1550 Court Place, Denver CO 80202. Hotel reservations at the group rate will remain available until February 1, 2020. A credit card is required at the time of booking.

The NAF group rate is $179 + taxes (currently 15.75%), per night.  Please note there is limited availability on discounted rate rooms.

Rooms must be booked directly through the hotel. Book a room online or by phone at (888) 627-8405. When booking a reservation by phone, request the National Ataxia Foundation group rate. If you require a room with two beds please note your request and communicate the number of people in your room when making your room reservation.

Sponsorship support for 2020 AIM provided by:

Interested in becoming an exhibitor?

Contact Joel Sutherland, Development Director at 763-231-2748 or

Previous AIM Photos


AIM 2018 Investigators Group Shot


AIM 2016 Investigators Group Shot


AIM 2014 Investigators Group Shot


AIM 2012 Investigators Group Shot


AIM 2010 Investigators Group Shot


Meeting Program (PDF) Links

Print Friendly, PDF & Email